Serveur d'exploration sur le thulium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

TRANSMYOCARDIAL LASER REVASCULARIZATION

Identifieur interne : 001197 ( Main/Exploration ); précédent : 001196; suivant : 001198

TRANSMYOCARDIAL LASER REVASCULARIZATION

Auteurs : Keith A. Horvath

Source :

RBID : PMC:4224272

Abstract

It has been almost a decade since transmyocardial laser revascularization (TMR) was approved for clinical use in the United States. The safety of TMR was demonstrated initially with non-randomized studies in which TMR was used as the only treatment for patients with severe angina. TMR efficacy was proven after multiple randomized controlled trials. These revealed significant angina relief compared to maximum medical therapy in patients with diffuse coronary disease not amenable to conventional revascularization. In light of these results, TMR has been used as an adjunct to coronary artery bypass grafting (CABG). By definition, patients treated with this combined therapy have more severe coronary disease and the co morbidities that are associated with end stage athorosclorosis. Combination CABG + TMR has resulted in symptomatic improvement without additional risk. The likely mechanism whereby TMR has provided benefit is the angiogenesis engendered by the laser-tissue interaction. Improved perfusion and concomitant improvement in myocardial function has been observed post TMR. Additional therapies to enhance the angiogenic response include combining TMR with stem cell based treatments which appear to be promising future endeavors.


Url:
DOI: 10.1111/j.1540-8191.2008.00579.x
PubMed: 18435649
PubMed Central: 4224272


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">TRANSMYOCARDIAL LASER REVASCULARIZATION</title>
<author>
<name sortKey="Horvath, Keith A" sort="Horvath, Keith A" uniqKey="Horvath K" first="Keith A." last="Horvath">Keith A. Horvath</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">18435649</idno>
<idno type="pmc">4224272</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224272</idno>
<idno type="RBID">PMC:4224272</idno>
<idno type="doi">10.1111/j.1540-8191.2008.00579.x</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">000333</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000333</idno>
<idno type="wicri:Area/Pmc/Curation">000333</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000333</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000335</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000335</idno>
<idno type="wicri:Area/Ncbi/Merge">000230</idno>
<idno type="wicri:Area/Ncbi/Curation">000230</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000230</idno>
<idno type="wicri:doubleKey">0886-0440:2008:Horvath K:transmyocardial:laser:revascularization</idno>
<idno type="wicri:Area/Main/Merge">001230</idno>
<idno type="wicri:Area/Main/Curation">001197</idno>
<idno type="wicri:Area/Main/Exploration">001197</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">TRANSMYOCARDIAL LASER REVASCULARIZATION</title>
<author>
<name sortKey="Horvath, Keith A" sort="Horvath, Keith A" uniqKey="Horvath K" first="Keith A." last="Horvath">Keith A. Horvath</name>
</author>
</analytic>
<series>
<title level="j">Journal of cardiac surgery</title>
<idno type="ISSN">0886-0440</idno>
<idno type="eISSN">1540-8191</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">It has been almost a decade since transmyocardial laser revascularization (TMR) was approved for clinical use in the United States. The safety of TMR was demonstrated initially with non-randomized studies in which TMR was used as the only treatment for patients with severe angina. TMR efficacy was proven after multiple randomized controlled trials. These revealed significant angina relief compared to maximum medical therapy in patients with diffuse coronary disease not amenable to conventional revascularization. In light of these results, TMR has been used as an adjunct to coronary artery bypass grafting (CABG). By definition, patients treated with this combined therapy have more severe coronary disease and the co morbidities that are associated with end stage athorosclorosis. Combination CABG + TMR has resulted in symptomatic improvement without additional risk. The likely mechanism whereby TMR has provided benefit is the angiogenesis engendered by the laser-tissue interaction. Improved perfusion and concomitant improvement in myocardial function has been observed post TMR. Additional therapies to enhance the angiogenic response include combining TMR with stem cell based treatments which appear to be promising future endeavors.</p>
</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Horvath, Keith A" sort="Horvath, Keith A" uniqKey="Horvath K" first="Keith A." last="Horvath">Keith A. Horvath</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001197 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001197 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    ThuliumV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4224272
   |texte=   TRANSMYOCARDIAL LASER REVASCULARIZATION
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:18435649" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ThuliumV1 

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu May 12 08:27:09 2016. Site generation: Thu Mar 7 22:33:44 2024